LC Method for Analysis of Three Flavonols in Rat Plasma and Urine after Oral Administration of Polygonum aviculare Extract

A high-performance liquid chromatographic method has been developed for the simultaneous analysis of the flavonols myricitrin (1), avicularin (2), and juglanin (3) in rat plasma and urine after oral administration of the total flavonoids from Polygonum aviculare. Samples were prepared by solid-phase extraction then separated on a C₁₈ reversed-phase column by use of a mobile-phase gradient prepared from methanol and aqueous formic acid solution. The flow rate was 1 mL min^?1. Detection was performed at 254 nm. The calibration range was 11–1,100 μg mL^?1 for both 2 and 3 in plasma; in urine the calibration ranges for 1, 2, and 3 were 32–1,600, 11–1,100, and 22–1,100 μg mL^?1, respectively. Intra-day and inter-day RSD were less than 4.33 and 3.62% for 2 and 3, respectively, in plasma, and no more than 4.03 and 2.22% for all the analytes in urine. The analytical sensitivity and selectivity of the assay enabled successful application to pharmacokinetic studies of flavonols 1–3 in rats.     

LC Method for the Determination of Rhaponticin in Rat Plasma, Faeces and Urine for Application to Pharmacokinetic Studies

A simple liquid chromatography (LC) method has been developed and validated to determine rhaponticin in rat plasma, faeces and urine. Chromatographic separation was achieved through mobile phase consisting of acetonitrile and water at a flow rate of 1.0 mL min^?1. Rhaponticin was quantified using UV detection at 324 nm. The assay was linear over the concentration range of 50–4,000 ng mL^?1 for plasma, faeces and urine. The intra- and inter-day RSD were less than 10%. The plasma, faeces and urine rhaponticin levels were monitored in rats after oral administration. This simple LC method appears to be useful in the pharmacokinetic investigation of rhaponticin.     

Quantitative Determination of Anti-Inflammatory Columbianetin in Rat Plasma by LC-ESI-MS/MS for Pharmacokinetic Studies after Oral Administration of Duhuo Extract

Specific LC-ESI-MS/MS method or procedure was developed and validated for columbianetin quantification in rat plasma using epicatechin as an internal standard (IS). Chromatographic separation was performed on an Eclipse plus C18 (150 × 4.6 mm, 1.8 ??m) at a flow rate of 0.300 mL min^?1, and water-acetonitrile was used as mobile phase. The calibration curve of the method was linear in the concentration range of 5?C1,000 ng mL^?1. The lower limit of quantification (LLOQ) was 5 ng mL^?1. The intra- and inter-day precision of the quality control samples was within 15.0%, and the accuracy was within 90.0?C110%. The recoveries were more than 90.0% for columbianetin at concentrations of 10, 200 and 1,000 ng mL^?1, respectively. This method was successfully applied for evaluation of the pharmacokinetics of columbianetin after oral doses of 0.60 g kg^?1 Angelica pubescence extract in rats.     

LC–MS Method for the Quantification of Clonazepam in Rat Plasma

A sensitive and specific high-performance liquid chromatography–tandem mass spectrometry method has been developed and validated for the determination of clonazepam in rat plasma. Clonazepam and internal standard diazepam were extracted from plasma samples by a single-step protein precipitation. The chromatographic separation was performed on a Dikma ODS-C18 reversed-phase column at 40 °C. The mobile phase composed of a premix of solvent A (0.1% formic acid–4 mM ammonium acetate–water)–solvent B (acetonitrile) (13:87, v/v) at a flow-rate of 0.7 mL min⁻¹. Positive electrospray ionization was utilized as the ionization source. Clonazepam and the internal standard were determined using multiple reaction monitoring of precursor → product ion transitions at m/z 316.0 → 270.0 and m/z 285.1 → 193.2, respectively. The lower limit of quantification was 0.25 ng mL⁻¹ using 50 μL plasma samples and the linear calibration range was from 0.25 to 128 ng mL⁻¹. The within- and between-batch RSDs were lower than 15% and the relative recoveries of clonazepam ranged from 97.4 to 104.7%. The mean extraction recoveries of clonazepam and IS were 79.7 and 77.6%, respectively. The method has been successfully applied to the pharmacokinetic studies in rat after oral administration of clonazepam.

     

LC Tissue Distribution Study of Paeonol in Rats after Oral Administration

Paeonol, an important constituent of the traditional Chinese medicine Cortex Moutan, has a variety of bioactivity. A simple and sensitive HPLC?CUV method has been developed for analysis of paeonol in different rat tissue (heart, liver, spleen, lung, kidney, and brain). Bio-samples were prepared by simple protein precipitation, and separation of paeonol was achieved on a C₁₈ column with methanol?C2% glacial acetic acid solution 70:30 (v/v) as mobile phase at a flow rate of 1.0 mL min^?1. UV detection was at 274 nm and the column temperature was 30 °C. Linearity was good between 0.025 and 5.0 ??g mL^?1 (r ² ?? 0.9990) for tissue samples. Inter-day and intra-day accuracy (as relative error, RE) and precision (as relative standard deviation, RSD) were <5.94 and 6.05%, respectively. The limit of detection was 0.025 ??g mL^?1 and extraction recovery for all samples was ??85.86%. The method was successfully applied to a tissue-distribution study after oral administration of 40 mg kg^?1 paeonol to healthy Sprague?CDawley rats. The study showed that paeonol was quickly distributed and eliminated after oral administration; liver and kidney were the major distribution tissues of paeonol in rats, and paeonol quickly passed through the blood?Cbrain barrier. It was also found there was no long-term accumulation of paeonol in rat tissues.     

Simultaneous Determination of Three Flavonoids in Rat Plasma by RP-LC After Oral Administration of the Total Flavonoids of Scutellaria barbata

A liquid chromatographic method for the simultaneous determination of three flavonoids, scutellarin (SCU), isoscutellarein-8-O-glucuronide (ISO) and luteolin (LUT) in rat plasma was developed and validated. Following a single-step liquid–liquid extraction with ethyl acetate, the analytes and internal standard (IS) (rutin) were successfully separated on a Diamonsil C₁₈ column using a mobile phase composed of acetonitrile (A)–0.2% phosphoric acid aqueous solution (B) (0–5 min, 20% A–29% A; 5–25 min, 29% A, v/v) at a flow rate of 1.0 mL min^?1. The linear range was 0.044–2.20 μg mL^?1 for SCU, 0.042–2.08 μg mL^?1 for ISO, and 0.056–2.80 μg mL^?1 for LUT, with the correlation coefficients of 0.9995, 0.9989 and 0.9963, respectively. The limit of quantification of SCU, ISO and LUT were 44, 41.6 and 56 ng mL^?1, respectively. The accuracy of assay was between 88.4 and 103.0%. The inter-day and intra-day precisions (RSD) were less than 10.5%. The developed method was simple, rapid and applied successfully to study the pharmacokinetics of SCU, ISO and LUT after oral administration of the total flavonoids of Scutellaria barbata.     

Metabolites of Icariin in Urine Following Oral Administration

YinyanghuohasbeenusedinfolkmedicineforthousandsofyearsinChina.ItbelongstoplansofgenusEpimedinm(Berberidaceae).ChinaPharmcopoeia(l995Ed.)c0llectedfivespeciesofEpAnedium,inwhichflavanoidsareregardedastheprinciPalcomPonentsresponsibleforthePharmacologicalactivitiesofYinyanghuo,suchastonic,anti-hyPertensiveandami-inflarnmatoryactions.Icariinisoneofthemainflav0n0idconstituentsinYinyanghuo"'andextensivelyusedtocontrolthequalityofthecmdedrug."'TherearemanyrePortsonthepharmac0l0gical,chendcaland…     

Determination of Daidzein in Rat Plasma by LC

Daidzein (4′,7-dihydroxylisoflavone), a water-insoluble isoflavone, is mainly present in leguminous plants. This study was aimed at investigating the absorption characteristics of daidzein across the intestinal membranes. Borneol has been used to enhance the intestinal absorption and bioavailability of daidzein. We chose an in vitro diffusion chamber system using isolated rat intestinal membranes as a model. A sensitive, accurate and reliable LC method was developed and validated to determine daidzein in rat plasma. A linear relationship for daidzein was found in the range of 20–800 ng mL^?1. The mean absolute recoveries of daidzein determined over three concentrations were 89.8 ± 4.8, 91.3 ± 2.8 and 95.4 ± 1.7%. The coefficients of variation for inter-day and intra-day assay were found to be less than 6.1%. The plasma concentration of daidzin following oral administration was significantly increased by coadministration of borneol in rats, and a 1.5-fold enhancement of relative bioavailability of daidzein was observed as compared to daidzein administered alone.     

LC Determination of Ketorolac in Human Plasma and Urine for Application to Pharmacokinetic Studies

A simple, specific and sensitive liquid chromatographic method has been developed for the assay of ketorolac in human plasma and urine. The clean-up of plasma and urine samples were carried out by protein precipitation procedure and liquid–liquid extraction, respectively. Separation was performed by a Waters sunfire C₁₈ reversed-phase column maintained at 35 °C. The mobile phase was a mixture of 0.02 M phosphate buffer (pH adjusted to 4.5 for plasma samples and to 3.5 for urine samples) and acetonitrile (70:30, v/v) at a flow rate of 1.0 mL min⁻¹. The UV detector was set at 315 nm. Nevirapine was used as an internal standard in the assay of urine sample. The method was validated over the concentration range of 0.05–8 and 0.1–10 μg mL⁻¹ for ketorolac in human plasma and urine, respectively. The limits of detection were 0.02 and 0.04 μg mL⁻¹ for plasma and urine estimation at a signal-to-noise ratio of 3. The limits of quantification were 0.05 and 0.1 μg mL⁻¹ for plasma and urine, respectively. The extraction recoveries were found to be 99.3 ± 4.2 and 80.3 ± 3.7% for plasma and urine, respectively. The intra-day and inter-day standard deviations were less than 0.5. The method indicated good performance in terms of specificity, linearity, detection and quantification limits, precision and accuracy. This assay demonstrated to be applicable for clinical pharmacokinetic studies.

     

LC Determination of Ketorolac in Human Plasma and Urine for Application to Pharmacokinetic Studies

A simple, specific and sensitive liquid chromatographic method has been developed for the assay of ketorolac in human plasma and urine. The clean-up of plasma and urine samples were carried out by protein precipitation procedure and liquid–liquid extraction, respectively. Separation was performed by a Waters sunfire C₁₈ reversed-phase column maintained at 35 °C. The mobile phase was a mixture of 0.02 M phosphate buffer (pH adjusted to 4.5 for plasma samples and to 3.5 for urine samples) and acetonitrile (70:30, v/v) at a flow rate of 1.0 mL min^?1. The UV detector was set at 315 nm. Nevirapine was used as an internal standard in the assay of urine sample. The method was validated over the concentration range of 0.05–8 and 0.1–10 μg mL^?1 for ketorolac in human plasma and urine, respectively. The limits of detection were 0.02 and 0.04 μg mL^?1 for plasma and urine estimation at a signal-to-noise ratio of 3. The limits of quantification were 0.05 and 0.1 μg mL^?1 for plasma and urine, respectively. The extraction recoveries were found to be 99.3 ± 4.2 and 80.3 ± 3.7% for plasma and urine, respectively. The intra-day and inter-day standard deviations were less than 0.5. The method indicated good performance in terms of specificity, linearity, detection and quantification limits, precision and accuracy. This assay demonstrated to be applicable for clinical pharmacokinetic studies.     

Rapid and Sensitive LC Method for the Analysis of Gemifloxacin in Human Plasma

A simple liquid chromatographic method for the determination of gemifloxacin (CAS number 175463-14-6) in human plasma has been developed. An aliquot quantity of 1 mL plasma sample was taken and 0.1 mL internal standard was added and mixed. 1 mL methanol was added to it. The mixture was then sonicated for 10 min followed by 20 min centrifugation at 5000 rpm (g = 3600). The supernatant layer was separated and filtered through simple filtration unit (membrane filter, 0.45 μm) and injected into the LC system consisting of Hypersil BDS, C18 (250 × 4.6 mm, 5 μm particle size) column, using 1% formic acid : methanol = 65:35 (v/v) as mobile phase with ultra violet detection at 328 nm. Lower limit of detection was 20 ng mL^?1 and lower limit of quantitation was 50 ng mL^?1. Maximum between-run precision was 14.614%. Mean extraction recovery was found to be 87.32 to 89.32%. Stability study showed that after three freeze-thaw cycles the loss of three quality control samples were less than 10%. Samples were stable at room temperature for 12 h and at ?20 °C for 3 months. Before injecting into LC system, the processed samples were stable for at least 8 h. The method was used to perform bioequivalence study in human volunteers.     

高效液相色谱-质谱联用技术测定鼻腔给药后人血浆中佐米曲普坦的含量

建立了经鼻腔给药后人血浆中佐米曲普坦的液相色谱-质谱联用测定方法。血浆样品经乙酸乙酯-二氯甲烷(体积比4∶1)液-液提取后,以Hypersil BDS C6H5柱(4.6 mm×250 mm,5μm)为色谱柱,流动相为乙腈(含1%甲酸)-0.02 mol.L-1醋酸铵(体积比30∶70),流速为0.6 mL.m in-1,柱温:25℃,进样量:40μL,在Agilent 1100 LC/MSD XCT离子阱质谱仪上,以选择离子监测(SIM)方式进行定量分析,用于监测的离子为m/z288(佐米曲普坦)和m/z296(舒马普坦,内标物)。佐米曲普坦的定量下限为0.30μg.L-1,线性范围为0.30~25μg.L-1,方法回收率在82%~87%之间(n=5),精密度与准确度符合生物样品分析要求。该法操作简便、快速、灵敏度高,可用于佐米曲普坦临床血药浓度和药代动力学研究。     

LC Method for Quantification of Lutein in Rat Plasma: Validation, and Application to a Pharmacokinetic Study

A reversed-phase LC method has been developed for quantitative analysis of lutein in rat plasma and applied to a study of the pharmacokinetics of lutein in rats. From a variety of compounds and solvents tested, astaxanthin was selected as the internal standard. n-Hexane was found to be the best solvent for extracting lutein from plasma. LC analysis of the extracts was performed on a C₁₈ column equipped with a guard pre-column. Linearity was good (r > 0.99) over the range 10–100 ng mL^?1. Recovery from plasma was 82.7–92.9% the intra-day and inter-day precision were always better than 3%. The limits of detection (LOD) and quantification (LOQ) were 2.5 and 8.3 ng mL^?1, respectively. The LC method was used to quantify lutein and zeaxanthin in rat plasma in a 36-h pharmacokinetic study in which experimental rats received a single oral dose of lutein (20 mg kg^?1). The results are presented.     

A Sensitive and Selective LC-MS Method for the Determination of Lurasidone in Rat Plasma,Bile, and Urine

A liquid chromatography-mass spectrometry (LC-MS) assay was developed and validated for the quantification of lurasidone, an atypical antipsychotic drug, in rat plasma, bile, and urine. Rat plasma, bile, or urine samples were processed by liquid–liquid extraction and injected onto an LC-MS system for the quantification of lurasidone and ziprasidone (an internal standard). Lurasidone and ziprasidone were separated from endogenous substances using a Gemini C6-Phenyl column with mixture of acetonitrile and 0.1 % formic acid (80:20, v/v) as the mobile phase. Quantification was performed using the selected ion monitoring mode at m/z 493 for lurasidone and m/z 413 for the IS. The detector response was specific and linear for lurasidone in the concentration range 5–5,000 ng mL⁻¹ The intra- and inter-day accuracy and precision of the method were determined to be within the acceptable criteria for assay validation guidelines. In addition, lurasidone was stable under a variety of processing and handling conditions. Lurasidone concentrations could be readily measured in rat plasma, bile, and urine samples up to 24 h after an intravenous or oral administration, suggesting that the assay can be used in pharmacokinetic studies of lurasidone in rats.

     

LC Method for Determination and Pharmacokinetic Study of 5,6,7,8,3′,4′-Hexamethoxy-3-sulfonyl Flavone in Rat Plasma

A sensitive, specific and rapid high-performance liquid chromatography method was developed for determination of 5,6,7,8,3′,4′-hexamethoxy-3-sulfonyl flavone in rat plasma. A simple methanol-induced protein precipitation was applied to extract 5,6,7,8,3′,4′-hexamethoxy-3-sulfonyl flavone and Picroside II (the internal standard) from rat plasma. Chromatographic separation was achieved on a Hypersil ODS₂ analytical column (200 mm × 4.6 mm, 5 μm) with acetonitrile–0.04% triethylamine solution (adjusted to pH 5.8 using phosphoric acid) (24:76, v/v) as mobile phase. The calibration curves were linear over the range of 0.2–40 μg mL⁻¹. Absolute recoveries of 5,6,7,8,3′,4′-hexamethoxy-3-sulfonyl flavone were 82.7–95.9% from rat plasma. The intra- and inter-day relative standard deviation precisions were less than 5 and 9%, respectively. The method was successfully applied to the pharmacokinetic study of 5,6,7,8,3′,4′-hexamethoxy-3-sulfonyl flavone in rats after intravenous administration.

     

Simple, Sensitive and Rapid LC–ESI–MS Method for the Quantitation of Olprinone in Rat Plasma

Olprinone is a phosphodiesterase (PDE)-3 inhibitor. This paper describes a simple, selective and sensitive method for the quantification of olprinone in rat plasma using a liquid–liquid extraction procedure followed by liquid chromatography mass spectrometric (LC–MS) analysis. The method had an advantage of high sensitivity. Analyses were conducted at a flow rate of 0.25 mL min⁻¹ by a gradient elution. The detection utilized selected ion monitoring in the positive ion mode at m/z 251.0 and 344.0 for the protonated molecular ions of olprinone and the internal standard, respectively. The quantitation limit for olprinone in rat plasma was 0.5 ng mL⁻¹. The linearity was also excellent over the concentration range of 0.5–100 ng mL⁻¹ of olprinone. The intra- and inter-day precision (relative standard deviation (RSD) %) was lower than 10%, and accuracy ranged from 90 to 110%. This developed method was successfully applied to analysis of olprinone in biological fluids.     

LC Determination and Pharmacokinetics Study of Mangiferin in Rat Plasma and Tissues

An LC method was developed for determination of mangiferin in rat plasma and tissues after oral administration of Rhizoma Anemarrhenae extract. Analysis was performed on a Gemini C₁₈ analytical column (250 × 4.6 mm, i.d.) with mobile phase consisting of acetonitrile–water (23:77, v/v) with 1% acetic acid and 1% tetrahydrofuran at a flow rate of 0.7 mL min⁻¹. Spinosin was used as internal standard and UV detector was set at 320 nm. The calibration curve of mangiferin in rat plasma and tissues showed excellent linear behaviors over the investigated concentration ranges with the value of R ² higher than 0.994. The within-day and between-day precisions for all samples were measured to be below 11.0%. The limit of quantitation was low enough for determination of mangiferin in all samples. After Rhizoma Anemarrhenae extract was orally administered to rats, the main pharmacokinetic parameters of mangiferin T _max, C _max, T _0.5α , T _0.5β , AUC_0 − T and Vc were 4.20 h, 9.52 μg mL⁻¹, 1.21 h, 1.71 h, 29.9 mg h L⁻¹ and 0.18 L kg⁻¹, respectively. Mangiferin was extensively distributed in most of the main tissues of rats. This validated method has been successfully applied to preliminary pharmacokinetics and tissue distribution study of mangiferin in rats.

     

LC Determination and Pharmacokinetics Study of Mangiferin in Rat Plasma and Tissues

An LC method was developed for determination of mangiferin in rat plasma and tissues after oral administration of Rhizoma Anemarrhenae extract. Analysis was performed on a Gemini C₁₈ analytical column (250 × 4.6 mm, i.d.) with mobile phase consisting of acetonitrile–water (23:77, v/v) with 1% acetic acid and 1% tetrahydrofuran at a flow rate of 0.7 mL min^?1. Spinosin was used as internal standard and UV detector was set at 320 nm. The calibration curve of mangiferin in rat plasma and tissues showed excellent linear behaviors over the investigated concentration ranges with the value of R ² higher than 0.994. The within-day and between-day precisions for all samples were measured to be below 11.0%. The limit of quantitation was low enough for determination of mangiferin in all samples. After Rhizoma Anemarrhenae extract was orally administered to rats, the main pharmacokinetic parameters of mangiferin T _max, C _max, T _0.5α , T _0.5β , AUC_0 ? T and Vc were 4.20 h, 9.52 μg mL^?1, 1.21 h, 1.71 h, 29.9 mg h L^?1 and 0.18 L kg^?1, respectively. Mangiferin was extensively distributed in most of the main tissues of rats. This validated method has been successfully applied to preliminary pharmacokinetics and tissue distribution study of mangiferin in rats.